IL-17A, IL-17F and IL-23 in patients with rheumatoid arthritis

IL-17A, IL-17F and IL-23 in patients with rheumatoid arthritis

The aim of the study was to determine the clinical and diagnostic value of interleukin (IL) 17A, IL-17F and IL-23 in rheumatoid arthritis (RA) patients in the advanced stage of the disease.Materials and methods. We examined 154 patients with a reliable diagnosis of RA according to ACR/EULAR (America...

Full description

Saved in:

Bibliographic Details
Main Authors:	Natalia A. Lapkina, Andrey A. Baranov, Olga P. Rechkina, Natalia E. Abaytova, Svetlana S. Zolotavkina, Alexander S. Artyuhov, Evgeny L. Nasonov
Format:	Article
Language:	Russian
Published:	IMA PRESS LLC 2024-09-01
Series:	Научно-практическая ревматология
Subjects:	rheumatoid arthritis il-17a il-17f il-23 disease activity
Online Access:	https://rsp.mediar-press.net/rsp/article/view/3607
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Xuetongsu attenuates synovial inflammation in rheumatoid arthritis by inhibiting the IL-23/IL-17/NF-κB inflammatory axis
by: Yuxin Chen, et al.
Published: (2025-08-01)

IL-17 in Protective Immunity to Vaginal Candidiasis
by: Baghdad Science Journal
Published: (2016-03-01)

Impact of Disease Activity-Guided Dose Reduction on IL-17 and IL-23 Inhibitors in Psoriasis: A Real-World Assessment of Efficacy, Safety, and Economic Benefits
by: Edoardo Cammarata, et al.
Published: (2025-07-01)

Effect of Aerobic Training with Aqueous Allium sativum L on IL-17, IL-22 Expression and Insulin Resistance in Diabetic Rats
by: Elnaz Sadeghpour Firozabadi, et al.
Published: (2023-03-01)

The study of pharmacodynamics of a medicine based on humanized monoclonal antibodies against IL-17 in rabbit model of antigen-induced arthritis
by: A. A. Nedorubov, et al.
Published: (2018-02-01)

The Impact of IL-17A Inhibition in Rheumatic and Musculoskeletal Diseases: Current Insights and Future Prospects
by: Sofia Ramiro, et al.
Published: (2025-04-01)

Interleukin biomarkers as predictive tools for lupus nephritis grade and disease activity in systemic lupus erythematosus
by: Dalia S. Saif, et al.
Published: (2025-04-01)

The Role of IL-6 and IL-17 in SARS CoV-2 Patients with Secondary Bacterial Pneumonia
by: May Raheem Ali, et al.
Published: (2023-02-01)

Cytokine dynamics in vitiligo: the roles of interleukin-10 and interleukin-17
by: Hanan Mohammed Saied
Published: (2025-08-01)

Diagnostic value of IL-17 in neurointoxication with mercury
by: B. G. Michailovna, et al.
Published: (2021-05-01)

Impact of IL-17A Inhibitors on Serum Uric Acid Levels in Psoriatic Patients with Hyperuricemia: A Prospective Observational Study
by: Wu C, et al.
Published: (2024-11-01)

LL-37 and citrullinated-LL-37 modulate IL-17A/F-mediated responses and selectively suppress Lipocalin-2 in bronchial epithelial cells
by: Anthony Altieri, et al.
Published: (2025-05-01)

Expression analysis of the IL-23/Th17 pathway in children with rhinovirus infection
by: Shu Teng, et al.
Published: (2025-07-01)

IL-17-neutralizing antibody mitigates functional and structural changes in cigarette smoke-induced COPD model
by: Alyne Riani Moreira, et al.
Published: (2025-08-01)

IL-17A inhibitors modulate skin microbiome in psoriasis: implications for microbial homeostasis
by: Ying Lv, et al.
Published: (2025-07-01)

The correlation between Th17/Treg immune dysregulation and the disease severity in chronic spontaneous urticaria patients
by: Xiaojing Yang, et al.
Published: (2023-07-01)

Fluoride induces hepatointestinal damage and vitamin B2 mitigation by regulating IL-17A and Bifidobacterium in ileum
by: Chen Liang, et al.
Published: (2025-06-01)

Izokibep: Preclinical development and first-in-human study of a novel IL-17A neutralizing Affibody molecule in patients with plaque psoriasis
by: Susanne Klint, et al.
Published: (2023-12-01)

IL-17 A expression negatively correlates with γδ T-Cell density in human psoriasis lesions: a novel implication for disease pathogenesis
by: Kubra Sevgin, et al.
Published: (2025-07-01)

ADAM17 selectively activates the IL‐6 trans‐signaling/ERK MAPK axis in KRAS‐addicted lung cancer
by: Mohamed I Saad, et al.
Published: (2019-03-01)

Blood cytokines as potential predictors of therapy effectiveness in patients with moderate to severe psoriasis treated with the IL-12/IL-23 inhibitor ustekinumab
by: Arfenya E. Karamova, et al.
Published: (2025-03-01)

DEVELOPMENT OF A REAL-TIME RT-PCR-BASED TEST PANEL FOR ASSESSMENT OF CYTOKINE PROFILE IN MONONUCLEAR CELLS FROM BLOOD AND SYNOVIAL FLUID IN RHEUMATOID ARTHRITIS
by: D. Yu. Trofimov, et al.
Published: (2014-07-01)

The absence of IL17A favours cytotoxic cell function and improves antigen‐specific immunotherapies in pancreatic adenocarcinoma
by: Giorgia Tiberi, et al.
Published: (2025-08-01)

Overexpression of Interleukin-17 Modulates Responses to Marek’s Disease Virus Infection and Tumor Formation in Chickens
by: Nitish Boodhoo, et al.
Published: (2025-07-01)

Retention rate of TNF inhibitors versus IL-17 inhibitors in ankylosing spondylitis patients with prior biologics experience
by: Jiwon Yang, et al.
Published: (2025-07-01)

Impact of Treatment Interruption on the Effectiveness of Interleukin (IL)-17A Inhibitors in Plaque Psoriasis: A Retrospective Analysis
by: Jiang J, et al.
Published: (2025-03-01)

TH-17 PHENOTYPE OF JUVENILE IDIOPATHIC ARTHRITIS
by: I. Z. Turtsevich1, et al.
Published: (2015-08-01)

Neutrophils negatively control IL-17A-producing γδ T cell frequencies in a contact-dependent manner under physiological conditions
by: Xinhua Yu, et al.
Published: (2025-03-01)

Gene polymorphisms of IL-1β (C511T), IL-17A (G197A), IL-12B (A1188C), TNFα (G308A) and IL-4 (C589T) associated with threat of early reproductive losses
by: E. A. Tatarkova, et al.
Published: (2020-01-01)

Plasma levels of IL-6, IL-10, IL-18, TNFα under the conditions of tobacco intoxication and after treatment with aminophthalhydrazide
by: O. V. Alpidovskaya
Published: (2024-04-01)

TGF‐β1 secreted by Tregs in lymph nodes promotes breast cancer malignancy via up‐regulation of IL‐17RB
by: Shih‐Chia Huang, et al.
Published: (2017-10-01)

Increased frequencies of human Th-17 CD4+ T-cells and decreased T-regulatory cells in patients with early and advanced metabolic dysfunction-associated steatotic liver disease
by: Elżbieta Supruniuk, et al.
Published: (2025-08-01)

Circulating Apelin-17 and Elabela Levels as Predictive Biomarkers of Neurodegeneration and Cognitive Decline in Alzheimer’s Disease
by: Shaimaa Imad Ali, et al.
Published: (2025-07-01)

ASSOCIATION OF rs4537545 (C>T) ALLELE POLYMORPHISM IN THE IL6R GENE WITH THE DEVELOPMENT OF RHEUMATOID ARTHRITIS
by: L. V. Topchieva, et al.
Published: (2020-06-01)

DEVELOPMENTS OF RUSSIAN ORIGINAL BIOLOGICAL AGENTS FOR THE TREATMENT OF IMMUNOINFLAMMATORY RHEUMATIC DISEASES
by: E. L. Nasonov, et al.
Published: (2017-04-01)

Evaluating the Efficacy of Bimekizumab Across Different Sensitive Areas in Moderate-to-Severe Psoriasis: 52-week Multicentric Real-Life Experience in Lazio, Italy
by: Annunziata Dattola, et al.
Published: (2025-04-01)

Serum Levels of IL-21 and IL-22 in Breast Cancer Patients—A Preliminary Study
by: Jacek Kabut, et al.
Published: (2025-07-01)

INTERGENIC INTERACTIONS OF TUMOR NECROSIS FACTOR ALPHA, INTERLEUKIN 17, AND OSTEOPROTEGERIN IN THE IMMUNOPATHOGENESIS OF RHEUMATOID ARTHRITIS IN THE RUSSIAN POPULATION OF THE CHELYABINSK REGION
by: Yulia Chumacheva, et al.
Published: (2019-08-01)

Correlation Between Interleukin IL-6/IL-6 Receptor Polymorphisms (<i>IL6</i>–174C>G and <i>IL6R</i> 1073A>C) and RAS/BRAF Mutations in Patients with Colorectal Cancer
by: Ekaterina Smagina, et al.
Published: (2025-02-01)

Long-Term Regulation of IL-17 Expression in Pacific Oyster Hemocytes by mGluR5 Through the Phosphoinositide Pathway
by: Yiran Si, et al.
Published: (2025-03-01)